Yüklüyor......
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials
BACKGROUND: Response rate (RR) alone may be insensitive to drug activity in phase II trials. Early progressive disease (EPD) could improve sensitivity as well as increase stage I stopping rates. This study compares the previously developed dual endpoint stopping rule (DESR), which incorporates both...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138426/ https://ncbi.nlm.nih.gov/pubmed/21693051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-11-95 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|